Anti-EphA2 Antibodies Decrease EphA2 Protein Levels in Murine CT26 Colorectal and Human MDA-231 Breast Tumors But Do Not Inhibit Tumor Growth

The EphA2 receptor tyrosine kinase has been shown to be over-expressed in cancer and a monoclonal antibody (mAb) that activates and down-modulates EphA2 was reported to inhibit the growth of human breast and lung tumor xenografts in nude mice. Reduction of EphA2 levels by treatment with anti-EphA2 s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: David Kiewlich, Jianhuan Zhang, Cynthia Gross, Wei Xia, Brent Larsen, Ronald R. Cobb, Sandra Biroc, Jian-Ming Gu, Takashi Sato, David R. Light, Tara Heitner, Joerg Willuda, David Vogel, Felipe Monteclaro, Andrzej Citkowicz, Steve R. Roffler, Deborah A. Zajchowski
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2006-01-01
Col·lecció:Neoplasia: An International Journal for Oncology Research
Matèries:
EphA2
ephrinAl
antibodies
colorectal cancer
breast cancer
Accés en línia:http://www.sciencedirect.com/science/article/pii/S1476558606800370
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars